Open Access Open Access  Restricted Access Subscription or Fee Access

Revolutionizing Healthcare: Cutting-Edge Biosensors Paving the Way for 21st Century Point-of-Care Diagnostics

Ushaa Eswaran, Vivek Eswaran, Keerthna Murali, Vishal Eswaran

Abstract


Point-of-care (POC) diagnostics stand as a transformative paradigm in healthcare, promising rapid testing directly at patient care sites. Biosensors, amalgamating biological recognition elements with physico-chemical transducers, emerge as pivotal tools in crafting rapid and sensitive POC diagnostic devices. Recent strides in nanotechnology, microfluidics, and flexible electronics have engendered a wave of innovative biosensor designs and detection methodologies. This paper provides an extensive review of the latest advancements in biosensors tailored explicitly for POC applications. Diving into signal transduction approaches, the exploration encompasses electrochemical, optical, piezoelectric, and magnetic methods, elucidating their diverse roles in facilitating POC diagnostics. Electrochemical techniques, encompassing amperometry and potentiometry, exhibit substantial promise in terms of sensitivity and real-time monitoring capabilities. Optical biosensors leverage fluorescence, surface plasmon resonance, and colorimetry, offering high specificity and rapid detection. Meanwhile, piezoelectric and magnetic biosensors unveil prospects for label-free and real-time monitoring in complex sample matrices. The integration of nanomaterials has revolutionized biosensor performance, where nanoparticles, nanowires, graphene, and 2D materials amplify sensitivity, specificity, and biocompatibility, nurturing the groundwork for ultra-sensitive POC devices. Concurrently, microfluidic systems have streamlined sample handling, ushering in miniaturization benefits, reduced analysis time, and heightened portability. Advancements in wearable biosensors, powered by flexible electronics, promise continuous monitoring and real-time data transmission, underpinning the pathway to personalized healthcare solutions. Furthermore, the synthesis of synthetic biology and metabolic engineering techniques augments biosensor performance, propelling tailored sensitivity, selectivity, and adaptability to an extensive spectrum of analytes. Delving beyond the realm of theoretical constructs, successful commercialization instances, such as glucose meters, underscore the viability of biosensor technology in healthcare. Looking forward, the trajectory of biosensors in POC diagnostics hinges on refining sensitivity thresholds, fortifying multiplexing capacities, advancing miniaturization for portability, and scaling manufacturability, thereby cementing their role as transformative agents poised to enhance patient care through rapid, cost-effective, and precise diagnostics.


Keywords


point-of-care diagnostics, biosensors, nanomaterials, microfluidics, wearable devices

Full Text:

PDF

References


Mohammed MI, Desmulliez MP. Lab-on-a-chip based immunosensor principles and technologies for the detection of cardiac biomarkers: a review. Lab on a Chip. 2011;11(4):569-95.

Yetisen AK, Akram MS, Lowe CR. based microfluidic point-of-care diagnostic devices. Lab on a Chip. 2013;13(12):2210-51.

Thakur MS, Ragavan KV. Biosensors in food processing. Journal of food science and technology. 2013 Aug;50:625-41.

Chin CD, Linder V, Sia SK. Lab-on-a-chip devices for global health: Past studies and future opportunities. Lab on a Chip. 2007;7(1):41-57.

Bandodkar AJ, Wang J. Non-invasive wearable electrochemical sensors: a review. Trends in biotechnology. 2014 Jul 1;32(7):363-71.

Kim J, Jeerapan I, Imani S, Cho TN, Bandodkar A, Cinti S, Mercier PP, Wang J. Noninvasive alcohol monitoring using a wearable tattoo-based iontophoretic-biosensing system. Acs Sensors. 2016 Aug 26;1(8):1011-9.

Liu Y, Yu D, Zeng C, Miao Z, Dai L. Biocompatible graphene oxide-based glucose biosensors. Langmuir. 2010 May 4;26(9):6158-60.

Kairdolf BA, Smith AM, Stokes TH, Wang MD, Young AN, Nie S. Semiconductor quantum dots for bioimaging and biodiagnostic applications. Annual review of analytical chemistry. 2013 Jun 12;6:143-62.

Perpetuini G, Di Nardo F, Rapino S, et al. Live cell metabolomics by electrochemical sensing system for inflammation and oxidative stress assessment. ACS Cent Sci. 2018;4(4):428-436.

Pardee K, Green AA, Ferrante T, Cameron DE, DaleyKeyser A, Yin P, Collins JJ. based synthetic gene networks. Cell. 2014 Nov 6;159(4):940-54.

Riglar DT, Giessen TW, Baym M, Kerns SJ, Niederhuber MJ, Bronson RT, Kotula JW, Gerber GK, Way JC, Silver PA. Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation. Nature biotechnology. 2017 Jul;35(7):653-8.

Rusling JF, Kumar CV, Gutkind JS, Patel V. Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer. Analyst. 2010;135(10):2496-511.

Wheeler EK, Benett W, Stratton P, et al. Microfluidic HIV test module. Proc SPIE Microfluid Diagn. 2009;7266:72660C.

Yoo EH, Lee SY. Glucose biosensors: an overview of use in clinical practice. Sensors. 2010 May 4;10(5):4558-76.

Pumera, M., Sofer, Z., Ambrosi, A., & Bonanni, A. (2007). Electrochemical sensing at nanodimension: nanoparticle, nanowire, and nanotube. Chemical Society Reviews, 39(11), 4146-4157.




DOI: https://doi.org/10.37628/ijibb.v9i2.870

Refbacks

  • There are currently no refbacks.